ADS-051

N/A

Report date: 2025/03/20 11:26:45
NMEFirst In Class

Base Information

Drug NameADS-051
Drug Alias NameBT-051ADS-051
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFormyl peptide receptor 1 antagonistsATP-binding cassette sub-family C member 2 inhibitorsNeutrophils modulators
TargetsATP-binding cassette sub-family C member 2Formyl peptide receptor 1
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandGeorgia +[4] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Massachusetts Medical School
China Registration ClassN/A

Develop Information

Active CompaniesUmass Medical School, Massachusetts - UsaAdiso Therapeutics Inc
Inactive CompaniesBacainn Therapeutics Inc
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A